Efficacy and Safety of Etoricoxib/Betamethasone Combination in Acute Bursitis, Tendinitis and Synovitis

NCT07328022 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

89

Enrollment

INDUSTRY

Sponsor class

Conditions

Bursitis
Tendinitis
Synovitis

Interventions

DRUG: Fixed Dose Etoricoxib + Betamethasone
DRUG: Monotherapy Etoricoxib

Sponsor

Laboratorios Silanes S.A. de C.V.